Global Dialysis - FDA: Myopathy risk of high-dose (80 mg) simvastatin close to 50%; limitations to use recommended.

FDA: Myopathy risk of high-dose (80 mg) simvastatin close to 50%; limitations to use recommended.

AHA: The United States Food and Drug Administration (FDA) today announced new limitations to the use of high-dose simvastatin, due to the increased risk of muscle pain and weakness (myopathy) and in rare cases, kidney damage and failure.

...